The DOI matches its Crossref record; 277 of the 277 references it cites were found in a registry or an index.
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Open accessAbstract
Inflammation occurs as a result of exposure of tissues and organs to harmful stimuli such as microbial pathogens, irritants, or toxic cellular components. The primary physical manifestations of inflammation are redness, swelling, heat, pain, and loss of function to the affected area. These processes involve the major cells of the immune system, including monocytes, macrophages, neutrophils, basophils, dendritic cells, mast cells, T-cells, and B-cells. However, examination of a range of inflammatory lesions demonstrates the presence of specific leukocytes in any given lesion. That is, the inflammatory process is regulated in such a way as to ensure that the appropriate leukocytes are recruited. These events are in turn controlled by a host of extracellular molecular regulators, including members of the cytokine and chemokine families that mediate both immune cell recruitment and complex intracellular signalling control mechanisms that characterise inflammation. This review will focus on the role of the main cytokines, chemokines, and their receptors in the pathophysiology of auto-inflammatory disorders, pro-inflammatory disorders, and neurological disorders involving inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–277 of 277
Danese, S., Colombel, J. F., Peyrin‐Biroulet, L., Rutgeerts, P., & Reinisch, W. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12284 · Cited by 100
Signaling Pathways Involved in IL-8-Dependent Activation of Adhesion Through Mac-1
Takami, M. S., Terry, V. H., & Petruzzelli, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4559 · Cited by 99
Clark, W. K., Jobanputra, P., Barton, P. M., & Burls, A. (2004) · Health Technology Assessment · doi:10.3310/hta8180 · Cited by 96
Tran, T. A. T., McCoy, M. K., Sporn, M. B., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-14 · Cited by 95
Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases
Savic, S., Dickie, L. J., Battellino, M., & McDermott, M. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834dd2d5 · Cited by 94
Laurie, C. D., Reynolds, A., Coskun, O., Bowman, E., Gendelman, H. E., & Mosley, R. L. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.009 · Cited by 93
Chemokines Indicate Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis
Hartl, D., Latzin, P., Zissel, G., Krane, M., Krauss‐Etschmann, S., & Griese, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1271oc · Cited by 93
Obici, L. P., Meini, A., Cattalini, M., Chicca, S., Galliani, M., Donadei, S., Plebani, A., & Merlini, G. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143438 · Cited by 93
Brennan, F. M., Gibbons, D. L., Cope, A. P., Feldmann, M., Mitchell, T. J., & Maini, R. N. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220734 · Cited by 91
Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells
Taupin, P. (2008) · International Journal of Medical Sciences · doi:10.7150/ijms.5.127 · Cited by 91
Gupta, S. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00195-4 · Cited by 89
Reefer, A. J., Satinover, S. M., Solga, M. D., Lannigan, J. A., Nguyen, J. T., Wilson, B. B., & Woodfolk, J. A. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.11.003 · Cited by 88
Distinct roles of diverse nuclear factor-κB complexes in neuropathological mechanisms
Pizzi, M., & Spano, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.027 · Cited by 88
Bank, I., Duvdevani, M., & Livneh, A. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2003.1 · Cited by 87
Reactive astrocytes and α1-antichymotrypsin in Alzheimer's disease
Abraham, C. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00302-5 · Cited by 87
Parkinson's disease and inflammatory changes
Barcia, C., Barreiro, A. F., Poza, M., & Herrero, M. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033170 · Cited by 85
McFarlane, S. M., Pashmi, G., Connell, M. C., LITTLEJOHN, A. F., Tucker, S. J., Vandenabeele, P., & MacEwan, D. J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02450-x · Cited by 83
Neurologic manifestations of the cryopyrin-associated periodic syndrome
Kitley, J., Lachmann, H. J., Pinto, A. A., & Ginsberg, L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d9ed69 · Cited by 83
Bonifati, V. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9324-y · Cited by 82
Nedjai, B., Hitman, G. A., Yousaf, N., Chernajovsky, Y., Stjernberg‐Salmela, S., Pettersson, T., Ranki, A., Hawkins, P. N., Arkwright, P. D., McDermott, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23123 · Cited by 78
Self-citationRilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS)
Hoffman, H. M. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902875518 · Cited by 77
Duque, J. S. R., Flores, R. L., Oliver, S. R., Pontello, A. M., Zaldivar, F. P., & Galassetti, P. R. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00243.x · Cited by 77
Hemmer, K., Fransen, L., Vanderstichele, H., Vanmechelen, E., & Heuschling, P. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00119-4 · Cited by 76
Kobayashi, N., Nagata, T., Shinagawa, S., Oka, N., Shimada, K., Shimizu, A., Tatebayashi, Y., Yamada, H., Nakayama, K., & Kondo, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.054 · Cited by 75
Hall, D. A., Beresford, I. J. M., Browning, C., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702329 · Cited by 74
Genetic models of Parkinson disease
Lim, K., & Ng, C.-H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.005 · Cited by 71
Shadidi, K. R., Aarvak, T., Henriksen, J. E., Natvig, J. B., & Thompson, K. M. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01214.x · Cited by 70
Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease
Schapira, A. H. V. (2009) · Neurology · doi:10.1212/wnl.0b013e3181990438 · Cited by 67
NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53
Liang, Z., Li, Y., Zhao, X.-L., Han, R., Wang, X., Wang, Y., Chase, T. N., Bennett, M. C., & Qin, Z. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.130 · Cited by 64
XCL1 Enhances Regulatory Activities of CD4+CD25highCD127low/− T Cells in Human Allergic Asthma
Nguyen, K. D., Fohner, A. E., Booker, J. D., Dong, C., Krensky, A. M., & Nadeau, K. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5386 · Cited by 64
Hesker, P. R., Nguyen, M., Kovářová, M., Ting, J. P. ‐., & Koller, B. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051105 · Cited by 63
Inflammation and infection in Parkinson's disease.
Arai, H., Furuya, T., Mizuno, Y., & Mochizuki, H. (2006) · PubMed · doi:10.14670/hh-21.673 · Cited by 62
Adeosun, S. O., Hou, X., Jiao, Y., Zheng, B., Henry, S., Hill, R., He, Z., Pani, A. K., Kyle, P. B., Ou, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050040 · Cited by 61
Lobito, A. A., Gabriel, T. L., Medema, J. P., & Kimberley, F. C. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.006 · Cited by 59
Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Nimmo, A. J., & Vink, R. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909788452997 · Cited by 58
Neuroimmunophilin ligands in the treatment of Parkinson's disease
Gold, B. G. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00125-4 · Cited by 57
Elzinga, B. M., Twomey, C., Powell, J. C., Harte, F. M., & McCarthy, J. V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803108200 · Cited by 57
Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease
Shah, B. J., & Mayer, L. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.45 · Cited by 56
Verjans, G. M. G. M., van Hagen, P. M., van der Kooi, A., Osterhaus, A. D. M. E., & Baarsma, G. S. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00208-4 · Cited by 55
Next stage of RA treatment: is TNF inhibitor-free remission a possible treatment goal?
Tanaka, Y. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202350 · Cited by 53
Tchélingérian, J., Saux, F. L., & Jacque, C. (1996) · Journal of Neuroscience Research · doi:10.1002/jnr.490430113 · Cited by 52
Portugal‐Cohen, M., Horev, L., Rüffer, C., Schlippe, G., Voss, W., Ma’or, Z., Oron, M., Soroka, Y., Frušić‐Zlotkin, M., Milner, Y., et al. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.12.009 · Cited by 52
Isik, N., Hereld, D., & Jin, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003424 · Cited by 51
Henderson, C., & Goldbach‐Mansky, R. T. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.02.013 · Cited by 48
Houman, H., Hamzaoui, A., Ghorbal, I. B., Khanfir, M. S., Feki, M., & Hamzaoui, K. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.07.005 · Cited by 47
Inflammation and Parkinsons Disease
Wersinger, C., & Sidhu, A. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344580 · Cited by 44
Glycosylation of interleukin‐6 purified from normal human blood mononuclear cells
Parekh, R. B., Dwek, R. A., Rademacher, T. W., Opdenakker, G., & Damme, J. V. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb19838.x · Cited by 44
Apoptosis of cultured microglia by the deprivation of macrophage colony-stimulating factor
Tomozawa, Y., Inoue, T., Takahashi, M., Adachil, M., & Satoh, M. (1996) · Neuroscience Research · doi:10.1016/0168-0102(96)01021-8 · Cited by 43
Serum and urinary cytokine levels of SLE patients
Brúgós, B. C., Vincze, Z., Sipka, S., Szegedi, G. Y., & Zeher, M. (2012) · Die Pharmazie · doi:10.31083/ph.2012.1694 · Cited by 42
The influence of glycosaminoglycans on IL-8-mediated functions of neutrophils
Schlorke, D., Thomas, L., Samsonov, S. A., et al. (2012) · Carbohydrate Research · doi:10.1016/j.carres.2012.02.025 · Cited by 42
Aubert, P. M., Suárez‐Fariñas, M., Mitsui, H., Johnson-Huang, L. M., Harden, J. L., Pierson, K. C., Dolan, J. G., Novitskaya, I., Coats, I., Estes, J. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049408 · Cited by 40
Chemokines in Allergic Aspergillosis - From Animal Models to Human Lung Diseases
Hartl, D., Buckland, K. F., & Hogaboam, C. M. (2006) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152806779010972 · Cited by 39
Turner, M. D., Chaudhry, A., & Nedjai, B. (2011) · Bioscience Reports · doi:10.1042/bsr20110089 · Cited by 39
Self-citationKlegeris, A., & McGeer, P. L. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7517 · Cited by 38
What Can Rodent Models Tell Us About Cognitive Decline in Alzheimer's Disease?
Davis, S., & Laroche, S. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:3:249 · Cited by 38
Churchman, S. M., Church, L. D., Savic, S., Coulthard, L., Hayward, B., Nedjai, B., Turner, M. D., Mathews, R. J., Baguley, E., Hitman, G. A., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.078667 · Cited by 37
Self-citationRecent developments in the treatment of inflammatory bowel disease
Rietdijk, S. T., & D’Haens, G. (2013) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12048 · Cited by 35
Immunotherapy in Inflammatory Bowel Disease
Ahluwalia, J. P. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.04.009 · Cited by 35
Regulation of prostaglandin E2 synthesis after brain irradiation
Moore, A. H., Olschowka, J. A., Williams, J. P., Okunieff, P., & O’Banion, M. K. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.035 · Cited by 35
Denmark, V. K., & Mayer, L. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.91 · Cited by 35
Yu, J. X., Bradt, B. M., & Cooper, N. R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00483-0 · Cited by 33
Impact of IL-1 signalling on experimental uveitis and arthritis
Planck, S. R., Woods, A., Clowers, J. S., Nicklin, M. J. H., Rosenbaum, J. T., & Rosenzweig, H. L. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200556 · Cited by 33
D’Astous, M., Steinmetz, K. R. M., Dluzen, D. E., & Paolo, T. D. (2005) · Neuroendocrinology · doi:10.1159/000091206 · Cited by 31
Inhibitors of tumor necrosis factor: New treatment options for rheumatoid arthritis
Vidt, D. G., & Moreland, L. W. (1999) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.66.6.367 · Cited by 29
Nilsson, L. N. G., Das, S., & Potter, H. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00043-2 · Cited by 28
Schütze, S., Loleit, T., Zeretzke, M., Bunkowski, S., Brück, W., Ribes, S., & Nau, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120856 · Cited by 27
Diverging Mechanisms of Activation of Chemokine Receptors Revealed by Novel Chemokine Agonists
Sarmiento, J., Shumate, C. K., Suetomi, K., Ravindran, A., Villegas, L., Rajarathnam, K., & Navarro, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027967 · Cited by 24
New guidelines for diagnosis of Parkinson disease
Martı́, M. J., & TOLOSA, E. S. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.47 · Cited by 20
Manzo, A., Caporali, R. F., Montecucco, C., et al. (2004) · PubMed · Cited by 19
Sakimoto, T., Yamada, A. Y., & Sawa, M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2669 · Cited by 18
Kautz‐Neu, K., Kostka, S. L., Dinges, S., Iwakura, Y., Udey, M. C., & von Stebut, E. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.99 · Cited by 17
Caspase-mediated cleavage of the signal-transducing IL-6 receptor subunit gp130
Graf, D., Haselow, K., Münks, I., Bode, J. G., & Häussinger, D. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.06.009 · Cited by 16
Cattalini, M., Meini, A., Monari, P., Gualdi, G., Arisi, M., Pelucchi, F., Bolognini, S., Gattorno, M., Calzavara‐Pinton, P., & Plebani, A. (2013) · Dermatology Online Journal · doi:10.5070/d31911020405 · Cited by 14
Moosmayer, D., Dinkel, A., Gerlach, E., Hessabi, B., Grell, M., Pfizenmaier, K., & Scheurich, P. (1994) · PubMed · Cited by 12
Shaping the gradient by nonchemotactic chemokine receptors
Borroni, E. M., & Bonecchi, R. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.2.8280 · Cited by 10
Goette, N. P., Lev, P. R., Heller, P. G., Glembotsky, A. C., Chazarreta, C. D., Salim, J. P., Molinas, F. C., & Marta, R. F. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.007 · Cited by 5
Sarmiento, J., Shumate, C. K., Suetomi, K., Ravindran, A., Villegas, L. N., Rajarathnam, K., & Navarro, J. (2012) · PLoS ONE · doi:10.1371/annotation/81d01b33-4eb2-459c-b600-0094d9f2d194 · Cited by 1
Cited by
Inflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143
Functional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
Combination strategies to maximize the benefits of cancer immunotherapy
Zhu, S., Zhang, T., Zheng, L., Liu, H., Song, W., Liu, D., Li, Z., & Pan, C.-X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01164-5 · Cited by 654
Metadata
- Authors
- Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 1843
- Issue
- 11
- Pages
- 2563-2582
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2118742454
- Cited by
- 2,162
- References
- 277
- FWCI
- 25.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.